FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...

BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC) ...

Becton, Dickinson and Company BDX — also popularly known as BD — recently received CE mark for its rapid, point-of-care, SARS-CoV-2 antigen test for utilization on the BD Veritor Plus System. The new ...

Poison Control is issuing a warning to anyone using at-home COVID-19 antigen tests. Many rapid antigen tests, including the BinaxNow, BD Veritor, Flowflex, and Celltrion DiaTrust tests, contain the ...

BD (Becton, Dickinson and Company), a leading global medical technology company, has started to ship the first over-the-counter (OTC) Covid-19 rapid antigen test to use computer vision technology in a ...

FRANKLIN LAKES, N.J. – USA Track & Field (USATF) and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide rapid COVID-19 testing for ...

The newly launched BD Veritor At-Home COVID-19 Test uses AI technology to promote better accuracy by reducing human error and allows you to share your results ...

New Jersey pharmaceutical firm Becton, Dickinson and Company has won approval from the U.S. Food and Drug Administration for a fast, easy-to-use test for novel coronavirus infections. At first glance, ...

Becton, Dickinson and Co. (BD) said today that it acquired its partner and key supplier in developing the BD Veritor™ System, privately held Alverix, in a $40 million deal designed to grow BD’s ...